Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs),...
The U.S. Food and Drug Administration (FDA) has approved Takeda's ENTYVIO (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely...
The European Commission (EC) has approved a Type II variation for Janssen-Cilag International NV's (a Johnson & Johnson company) CARVYKTI (ciltacabtagene autoleucel; cilta-cel).
This latest...